Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
The Thyroid Gland01:23

The Thyroid Gland

6.8K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
6.8K
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

5.0K
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
5.0K
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

7.3K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.3K
Muscles of the Eye01:20

Muscles of the Eye

4.0K
The muscles of the eye are sophisticated structures that control eye movement and focus, allowing for the precise and rapid adjustments necessary for vision. The human eye is controlled by ten muscles — six extraocular muscles, three intraocular muscles, and one primary eyelid retractor muscle.
Extraocular Muscles
The six extraocular muscles surround the eyeball and control its movements. They are responsible for a wide range of eye motions, including looking up, down, left, right, and...
4.0K
Accessory Structures of the Eye01:17

Accessory Structures of the Eye

3.4K
Optical perception, or vision, is an extraordinary sense dependent on converting light signals received via the ocular organs. These organs, known as eyes, are securely positioned within the bony cavities of the skull, called orbits. The orbits serve a dual purpose: a protective shield for the ocular globes and a stable attachment point for the soft ocular tissues. The eye's external protective mechanisms include the eyelids, which are edged with lashes that act as a barrier against foreign...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Euthyroidism and Long-Term Remission of Graves' Hyperthyroidism Following Treatment With an FcRn Blocker: A Case Report.

Thyroid : official journal of the American Thyroid Association·2026
Same author

Secukinumab in Moderate-to-Severe Graves Orbitopathy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study.

The Journal of clinical endocrinology and metabolism·2025
Same author

Type 1 Diabetes and Other Autoimmune Diseases-Epidemiology, Pathophysiology and Screening.

Endocrinology, diabetes & metabolism·2025
Same author

Comparison of the 2021 EUGOGO guidelines and the 2022 ATA/ETA consensus statement for the management of Graves' orbitopathy.

European thyroid journal·2025
Same author

Graves' disease in ectopic thyroid tissue: a scoping review and a case study.

European thyroid journal·2025
Same author

Unravelling the pathogenic mechanisms in Graves' orbitopathy.

European thyroid journal·2025
Same journal

EDITORIAL INTRODUCTION.

Current opinion in endocrinology, diabetes, and obesity·2026
Same journal

Exploring the role of parathyroid hormone in sarcopenia: A review.

Current opinion in endocrinology, diabetes, and obesity·2026
Same journal

Normocalcemic primary hyperparathyroidism: an update on diagnostic and management challenges.

Current opinion in endocrinology, diabetes, and obesity·2026
Same journal

Prediabetes before pregnancy: implications for risk stratification and research.

Current opinion in endocrinology, diabetes, and obesity·2026
Same journal

Secondary hyperparathyroidism in chronic kidney disease: update on pathophysiology and new treatment targets.

Current opinion in endocrinology, diabetes, and obesity·2026
Same journal

Revisiting the relationship between weight loss and bone health in people living with obesity: insights from the latest evidence.

Current opinion in endocrinology, diabetes, and obesity·2026
See all related articles

Related Experiment Video

Updated: Jan 21, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

2.4K

Immunotherapies for thyroid eye disease.

George J Kahaly1

  • 1Department of Medicine I, Johannes Gutenberg University Medical Center, Mainz, Germany.

Current Opinion in Endocrinology, Diabetes, and Obesity
|July 30, 2019
PubMed
Summary
This summary is machine-generated.

New treatments for thyroid eye disease (TED) show promise beyond steroids. Targeted therapies like teprotumumab and rituximab offer improved outcomes for this autoimmune condition affecting vision and quality of life.

More Related Videos

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

2.2K
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

21.6K

Related Experiment Videos

Last Updated: Jan 21, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

2.4K
Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

2.2K
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

21.6K

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Autoimmune Diseases

Background:

  • Thyroid eye disease (TED) is a debilitating autoimmune disorder causing orbital disfigurement, double vision, and vision loss.
  • Current treatments like steroids have limitations, including recurrence and incomplete anatomical restoration.
  • Novel therapeutic strategies are needed to address the underlying pathophysiology and improve patient outcomes.

Purpose of the Study:

  • To review recent advancements in understanding and treating thyroid eye disease.
  • To highlight emerging therapeutic targets and their clinical implications.
  • To summarize novel treatment strategies beyond conventional steroid therapy.

Main Methods:

  • Review of recent clinical trials and research findings in thyroid eye disease.
  • Analysis of new potential therapeutic targets identified in the last decade.
  • Synthesis of data on antiproliferative and targeted biologic therapies.

Main Results:

  • Antiproliferative agents (e.g., mycophenolate sodium) may prevent deterioration after steroid withdrawal.
  • Targeted biologic therapies show significant promise: teprotumumab (anti-IGFR) reduces proptosis, rituximab (anti-CD20) reduces inflammation, and tocilizumab (anti-IL-6) may benefit both.
  • These novel therapies offer potential for more effective management of TED.

Conclusions:

  • Recent research has identified new therapeutic targets for thyroid eye disease.
  • Targeted biologic therapies represent a significant advancement in managing TED, offering improved efficacy and outcomes.
  • Further research and clinical application of these novel treatments are warranted to improve patient quality of life.